RENHENG ENT released its interim results, with a net profit of HKD 13.058 million, a year-on-year increase of 72.8%
RENHENG ENT released its mid-term results for 2025, with a net profit of HKD 13.058 million, a year-on-year increase of 72.8%. Revenue was HKD 60.64 million, a year-on-year decrease of 0.6%. The basic earnings per share were HKD 0.0162, and the gross profit margin was 45.5%, an increase of 11.4% from the previous period's 34.1%. The gross profit margin for the construction contracts of flavoring and fragrance machinery for tobacco increased from 32.2% to 45.8%
According to the Zhitong Finance APP, RENHENG ENT (03628) released its mid-term results for 2025, with revenue of HKD 60.64 million, a year-on-year decrease of 0.6%; net profit of HKD 13.058 million, a year-on-year increase of 72.8%; and basic earnings per share of HKD 0.0162.
During this period, the gross profit margin was 45.5%, an increase of 11.4% from the previous period's 34.1%. In terms of product gross profit margin, the gross profit margin from the contracts for the blending of tobacco flavoring and the construction of flavoring machinery increased from 32.2% in the first half of 2024 to 45.8% in the first half of 2025
